These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37140664)

  • 1. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
    Bausch K; Zahiti L; Schrutt M; Wetterauer C; Halbeisen FS; Ebbing J; Seifert HH
    World J Urol; 2023 Jun; 41(6):1605-1612. PubMed ID: 37140664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world evidence with The Rezūm System: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes.
    Ines M; Babar M; Singh S; Iqbal N; Ciatto M
    Prostate; 2021 Sep; 81(13):956-970. PubMed ID: 34254333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
    Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
    Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review.
    Babar M; Loloi J; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2022 May; 14(3):140-154. PubMed ID: 35233955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.
    Alegorides C; Fourmarier M; Eghazarian C; Lebdai S; Chevrot A; Droupy S
    Prog Urol; 2020 Oct; 30(12):624-631. PubMed ID: 32826195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
    Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
    Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
    Bassily D; Wong V; Phillips JL; Fraiman M; Bauer R; Dixon CM; Wong NC
    Prostate; 2021 Oct; 81(14):1049-1054. PubMed ID: 34287992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.
    Siena G; Cindolo L; Ferrari G; Maruzzi D; Fasolis G; Condorelli SV; Varvello F; Visalli F; Rabito S; Toso S; Caroassai S; Mari A; Viola L; Somani BK; Carini M
    World J Urol; 2021 Oct; 39(10):3875-3880. PubMed ID: 33787986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
    Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
    J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezūm® steam system.
    Fernández-Guzmán E; Asensio Matas A; Capape Poves V; Rioja Zuazu J; Garrido Abad P; Martínez-Salamanca JI; Quintana Franco LM; Justo-Quintas J; Romero-Otero J; Domínguez-Esteban M
    Actas Urol Esp (Engl Ed); 2022 Jun; 46(5):310-316. PubMed ID: 35570100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre.
    Winkler T; von Klot CAJ; Madersbacher S; Kuczyk MA; Wolters M
    PLoS One; 2023; 18(1):e0279883. PubMed ID: 36607843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Real-World Short-Term Outcomes of a Failed Trial of Void After Rezum Therapy in a Multiethnic Population.
    Babar M; Labagnara K; Loloi J; Tang K; Ines M; Singh S; Iqbal N; Ciatto M
    J Endourol; 2023 Jan; 37(1):67-73. PubMed ID: 36029212
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data.
    Cho MC; Yoo S; Park J; Cho SY; Son H; Oh SJ; Paick JS
    BJU Int; 2019 May; 123(5A):E34-E42. PubMed ID: 30582661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Rezum therapy as a minimally invasive modality for management of Benign Prostatic Hyperplasia: A prospective observational study.
    Abouelgreed TA; Koritenah AK; Badran Y; Tagreda I; Algammal M; Abozied H; Eldamanhory HA; Shouman HA; Khattab AA; Ali M; Alnajem MT; Abdelwahed AA
    Arch Ital Urol Androl; 2023 Dec; 95(4):12026. PubMed ID: 38193224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot Study of "Less is More" Rezum for Treatment of BPH.
    Aladesuru O; Amankwah K; Elterman D; Zorn KC; Bhojani N; Te A; Chughtai B
    Urology; 2022 Jul; 165():256-260. PubMed ID: 35139413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis.
    Miller LE; Chughtai B; McVary K; Gonzalez RR; Rojanasarot S; DeRouen K; Bhattacharyya S
    Medicine (Baltimore); 2020 Jul; 99(30):e21365. PubMed ID: 32791742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year outcomes after water vapor thermal therapy for symptomatic benign prostatic hyperplasia in an unselected Italian multicenter cohort.
    Cindolo L; Morselli S; Campobasso D; Conti E; Sebastiani G; Franzoso F; Galluccio G; Maruzzi D; Visalli F; Varvello F; Lucci Chiarissi M; Viola L; Sessa F; Toso S; Micali S; Ferrari G; Siena G
    Minerva Urol Nephrol; 2023 Apr; 75(2):203-209. PubMed ID: 36656128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.